In 1978 at the haemophilia centre at Leeds, based at St James's University Hospital very little cryoprecipitate was in use. Read more about In 1978 at the haemophilia centre at Leeds, based at St James's University Hospital very little cryoprecipitate was in use.
The haemophilia centre at Leeds, based at St James's University Hospital showed no evidence of batch dedication or evidence of risk reduction. Read more about The haemophilia centre at Leeds, based at St James's University Hospital showed no evidence of batch dedication or evidence of risk reduction.
By 1977 the haemophilia centre at Leeds, based at St James's University Hospital were using a substantial amount of commercial concentrates. Read more about By 1977 the haemophilia centre at Leeds, based at St James's University Hospital were using a substantial amount of commercial concentrates.
In 1970, at the haemophilia centre at Leeds, based at St James's University Hospital Dr Layinka Swinburne was the director and in 1985, she was joined by Dr Bernard McVerry. Read more about In 1970, at the haemophilia centre at Leeds, based at St James's University Hospital Dr Layinka Swinburne was the director and in 1985, she was joined by Dr Bernard McVerry.
In December 1979, the Haemophilia Working Party met and discussed the fact that up to 70% of patients with severe haemophilia had abnormal liver function tests, with a wide spectrum of histological abnormalities. Read more about In December 1979, the Haemophilia Working Party met and discussed the fact that up to 70% of patients with severe haemophilia had abnormal liver function tests, with a wide spectrum of histological abnormalities.
In 1979 Dr Kernoff and Dr Colvin authorised guidelines for the screening and investigation of liver functioning and Hepatitis B tests, implementing closer monitoring of patients. Read more about In 1979 Dr Kernoff and Dr Colvin authorised guidelines for the screening and investigation of liver functioning and Hepatitis B tests, implementing closer monitoring of patients.
In 1979, Dr Kernoff described NANBH was a serious disease with long-term consequences. Read more about In 1979, Dr Kernoff described NANBH was a serious disease with long-term consequences.
In 1979, Dr Kernoff held that while cryoprecipitate was cheap to produce it had serious clinical disadvantages and that the NHS's shortfall had to be addressed through buying commercial concentrate. Read more about In 1979, Dr Kernoff held that while cryoprecipitate was cheap to produce it had serious clinical disadvantages and that the NHS's shortfall had to be addressed through buying commercial concentrate.
Dr Hill reported to the December 1979 meeting of the West Midlands Working Party that the Hepatitis Working Party had reported that Commercial Factor VIII carried the risk of hepatitis, and he was concerned that some children at the Childrens Hospital had become hepatitis carriers Read more about Dr Hill reported to the December 1979 meeting of the West Midlands Working Party that the Hepatitis Working Party had reported that Commercial Factor VIII carried the risk of hepatitis, and he was concerned that some children at the Childrens Hospital had become hepatitis carriers
By 1975 Dr Colvin was aware that there was at least a possibility of chronic liver disease in haemophilia Read more about By 1975 Dr Colvin was aware that there was at least a possibility of chronic liver disease in haemophilia